Diacylglycerol Ameliorates Obesity-Induced Osteoporosis through inhibiting NF-κB pathway Mediated Osteoclast Differentiation

Key Points

• To explore the effects of diacylglycerol on obesity-induced osteoporosis and the mechanisms involved.
• Investigated the role of diacylglycerol in inhibiting NF-κB pathway activation.
• Examined osteoclast differentiation in an obesity model.
• Performed biochemical assays to assess lipid metabolism.
• Diacylglycerol significantly reduced osteoclast differentiation.
• Inhibition of the NF-κB pathway was observed with diacylglycerol treatment.
• There was a correlation between reduced obesity-related bone loss and diacylglycerol administration.